The Food and Drug Administration approved Gilead's Harvoni drug that aims to cure hepatitis C. It costs $94,500 over a 12-week program, equivalent to $1,125 daily.
FDA approves Gilead's Harvoni drug: Can we afford the $1125 once-a-day Hepatitis C pill?
Tech Times - 11 Oct 2014 12:52
The Food and Drug Administration approved Gilead's Harvoni drug that aims to cure hepatitis C. It costs $94,500 over a 12-week program, equivalent to $1,125 daily.
Share this Article
Recommended